Knights Of Columbus Asset Advisors LLC Seagen Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$191.51 - $216.16 $70,858 - $79,979	370 Added 2.68%	14,158 $3 Million
Q2 2023 Jul 31, 2023	BUY	$187.64 - $206.25 $9,382 - $10,312	50 Added 0.36%	13,788 $2.65 Million
Q1 2023 May 01, 2023	BUY	$127.59 - $203.08 $46,697 - $74,327	366 Added 2.74%	13,738 $2.78 Million
Q4 2022 Jan 31, 2023	SELL	$117.37 - $139.17 $283,800 - $336,513	-2,418 Reduced 15.31%	13,372 $1.72 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $236,722 - $315,192	1,750 Added 12.46%	15,790 $2.16 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $28,399 - $46,805	261 Added 1.89%	14,040 $2.48 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $6,578 - $8,681	-55 Reduced 0.4%	13,779 $1.99 Million
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $1.97 Million - $2.64 Million	13,834 New	13,834 $2.14 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.